The therapeutic drug monitoring market is projected to reach USD 2.55 billion by 2020 from USD 1.78 billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020). In this report, the therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region.
Download Brochure at Therapeutic Drug Monitoring Market spread across 194 pages, Profiling 11 Companies and supported with 174 Tables and 46 Figures is now available at www.reportsnreports.com/contacts/r….aspx?name=518327 .
Technological advances in tests used to monitor therapeutic drugs, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are the major drivers for the market. Adjunct technologies such as biomarker identification using proteomics to accurately identify clinical outcomes and genetic testing are expected to benefit the growth of the therapeutic drug monitoring market.
1 Therapeutic Drug Monitoring: Market Overview
2 Geographical Analysis: Market, By Classes of Drug (2015)
3 Geographical Snapshot of the Market, 2015
4 Market, By Technology
5 Its Equipment Market, By Type
North America is expected to account for more than half the therapeutic drug monitoring market share in 2015.
It is the prime market for therapeutics drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure.
Get More Information on Therapeutics Drug Monitoring Market with Top Trends and Company Profiles at www.reportsnreports.com/contacts/.aspx?name=518327 .
Competitive landscape covers the various strategies adopted by industry players to maintain their position in the therapeutic drug monitoring market. The company profiles comprise the basic views on the key players in the therapeutic drug monitoring market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares.
Therapeutic Drug Monitoring Market, By Class of Drug
3 Antiarrhythmic Drugs
7 Psychoactive Drugs
Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc.
(U.S.), and Danaher Corporation (U.S.).
Growth in the APAC therapeutic drug monitoring market is comparatively slower due to the dearth of skilled healthcare personnel for performing therapeutic drug monitoring tests with minimal errors.
Therapeutic drugs monitor market, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are major drivers for therapeutic drug monitoring market. Adjunct technologies like biomarker identification using proteomics to accurately identify clinical outcome & genetic testing are expected to benefit growth of market.